MIRA PHARMACEUTICALS, INC. (MIRA) › Cash & EquivalentsMIRA PHARMACEUTICALS, INC. (MIRA) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2024: $2.83M2025: $6.35M$6.35M2024Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$6.35M+124.0%2024$2.83M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share